Portfolio company Mesosil received its first FDA 510(k) clearance for its antimicrobial additive technology.
FEB 11, 2026
Toronto-based materials science company developing and manufacturing nanostructured silica antimicrobial and bioactive additives for dental materials and medical devices
Toronto-based materials science company developing and manufacturing nanostructured silica antimicrobial and bioactive additives for dental materials and medical devices. Its platform delivers high-capacity, sustained release of bioactive agents and can be integrated into manufacturers’ existing materials and workflows. The technology is FDA 510(k)-cleared for an initial medical-device application and is intended to reduce infection, biofilm formation, and material degradation.